Inhibition of SARS‐CoV‐2 replication using calcineurin inhibitors: are concentrations required clinically achievable?

Authors :: N Padullés
Gemma Rocamora-Blanch
Jordi Niubó
Xavier Solanich
Xavier Corbella
Arnau Antolí
Sebastián Videla
Source :: Journal of Internal Medicine. 289:926-927
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Calcineurin
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
Viral replication
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Replication (statistics)
Internal Medicine
Medicine
business
Virology

Full Text Access

Tools